Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Prostaglandin D2 receptor 2 | ||
Ligand | BDBM50401101 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_884446 (CHEMBL2212208) | ||
IC50 | >1000±n/a nM | ||
Citation | Kaila, N; Huang, A; Moretto, A; Follows, B; Janz, K; Lowe, M; Thomason, J; Mansour, TS; Hubeau, C; Page, K; Morgan, P; Fish, S; Xu, X; Williams, C; Saiah, E Diazine indole acetic acids as potent, selective, and orally bioavailable antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases. J Med Chem55:5088-109 (2012) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Prostaglandin D2 receptor 2 | |||
Name: | Prostaglandin D2 receptor 2 | ||
Synonyms: | CD_antigen=CD294 | CRTH2 | Chemoattractant Receptor-homologous molecule expressed on T-helper type 2 cells (CRTH2) | Chemoattractant receptor-homologous molecule expressed on Th2 cells | Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) | DL1R | G protein-coupled receptor 44 | G-protein coupled receptor 44 | GPR44 | PD2R2_HUMAN | PTGDR2 | Prostaglandin D2 | Prostaglandin D2 receptor 2 | Prostaglandin D2 receptor 2 (PGD2) | ||
Type: | Enzyme | ||
Mol. Mass.: | 43295.45 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9Y5Y4 | ||
Residue: | 395 | ||
Sequence: |
| ||
BDBM50401101 | |||
n/a | |||
Name | BDBM50401101 | ||
Synonyms: | CHEMBL2205155 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H19N7O | ||
Mol. Mass. | 433.4647 | ||
SMILES | Cc1c(-c2nn(Cc3ccccc3)c(=O)c3ccccc23)c2ccccc2n1-c1nnn[nH]1 |(26.03,-37.21,;24.5,-37.21,;23.58,-35.96,;24.36,-34.63,;25.9,-34.64,;26.67,-33.31,;28.21,-33.32,;28.98,-34.65,;28.19,-35.97,;28.96,-37.31,;30.5,-37.32,;31.27,-35.98,;30.51,-34.65,;25.91,-31.97,;26.68,-30.64,;24.37,-31.97,;23.59,-30.63,;22.05,-30.63,;21.28,-31.98,;22.05,-33.31,;23.59,-33.31,;22.11,-36.44,;20.77,-35.67,;19.45,-36.44,;19.44,-37.99,;20.78,-38.76,;22.11,-37.99,;23.58,-38.46,;24.06,-39.93,;25.53,-40.4,;25.53,-41.94,;24.07,-42.42,;23.16,-41.17,)| | ||
Structure |